Cite

HARVARD Citation

    O'Rawe, M. et al. (2022). Treatment of glioblastoma with re-purposed renin-angiotensin system modulators: Results of a phase I clinical trial. Journal of clinical neuroscience. pp. 48-54. [Online]. 
  
Back to record